Published in Cancer Weekly, November 6th, 1995
The CPMP recommendation follows the October 16, 1995, decision of the Oncologic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) to recommend that the FDA grant marketing clearance for Fareston for use in treating locally advanced and advanced breast cancer in post-menopausal women.
Schering-Plough also reported that...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.